UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long‐term outcome of enzyme‐replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications

Journal of internal medicine, 2013-10, Vol.274 (4), p.331-341

2013

Volltextzugriff (PDF)

Chronic kidney disease and statin therapy: to treat or not to treat?

European heart journal, 2013-06, Vol.34 (24), p.1772-1774, Article 1772

Wanner, C

2013

Volltextzugriff (PDF)

A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease

Kidney international, 2008-02, Vol.73 (4), p.391-398

2008

Volltextzugriff (PDF)

Rare lysosomal disease registries: lessons learned over three decades of real-world evidence

Orphanet journal of rare diseases, 2022-10, Vol.17 (1), p.362-362, Article 362

2022

Volltextzugriff (PDF)

Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study

European journal of preventive cardiology, 2021-08, Vol.28 (9), p.924-934

2021

Volltextzugriff (PDF)

First Treatment of Relapsing Rapidly Progressive IgA Nephropathy With Eculizumab After Living Kidney Donation: A Case Report

Transplantation proceedings, 2017-09, Vol.49 (7), p.1574-1577

2017

Volltextzugriff (PDF)

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease

European heart journal, 2022-04, Vol.43 (14), p.1416-1424

2022

Volltextzugriff (PDF)

Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials

Nephrology, dialysis, transplantation, 2019-07, Vol.34 (7), p.1112-1114

2019

Volltextzugriff (PDF)

The D313Y genotype—Pathogenic mutation or polymorphism?

Clinical genetics, 2018-06, Vol.93 (6), p.1257-1257

2018

Volltextzugriff (PDF)

Stratification of Fabry mutations in clinical practice: a closer look at α‐galactosidase A‐3D structure

Journal of internal medicine, 2020-11, Vol.288 (5), p.593-604

2020

Volltextzugriff (PDF)

Low homoarginine concentration is a novel risk factor for heart disease

Heart (British Cardiac Society), 2011-08, Vol.97 (15), p.1222-1227

2011

Volltextzugriff (PDF)

Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration

Nephrology, dialysis, transplantation, 2010-01, Vol.25 (1), p.212-218

2010

Volltextzugriff (PDF)

Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study

Nephrology, dialysis, transplantation, 2011-03, Vol.26 (3), p.1024-1032

2011

Volltextzugriff (PDF)

Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Kidney international, 2006-12, Vol.70 (12), p.2058-2065

2006

Volltextzugriff (PDF)

Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry

Nephrology, dialysis, transplantation, 2015-06, Vol.30 (6), p.1028-1037

2015

Volltextzugriff (PDF)

Ocular sarcoidosis

Zeitschrift für Rheumatologie, 2017-06, Vol.76 (5), p.391-397

2017

Volltextzugriff (PDF)

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

Nephrology, dialysis, transplantation, 2012-03, Vol.27 (3), p.1042-1049

2012

Volltextzugriff (PDF)

Clinical benefit of enzyme replacement therapy in Fabry disease

Kidney international, 2006-04, Vol.69 (7), p.1216-1221

2006

Volltextzugriff (PDF)

Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome

Nephrology, dialysis, transplantation, 2003-07, Vol.18 (7), p.1272-1280

2003

Volltextzugriff (PDF)

Impact of immunosuppressive therapy on therapy‐neutralizing antibodies in transplanted patients with Fabry disease

Journal of internal medicine, 2017-09, Vol.282 (3), p.241-253

2017

Volltextzugriff (PDF)

C‐reactive protein a marker for all‐cause and cardiovascular mortality in haemodialysis patients

Nephrology, dialysis, transplantation, 2002-01, Vol.17 (suppl-8), p.29-32

2002

Volltextzugriff (PDF)

Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry

Nephrology, dialysis, transplantation, 2014-09, Vol.29 Suppl 4 (suppl 4), p.iv1-iv8

2014

Volltextzugriff (PDF)

Haemodiafiltration at increased plasma ionic strength for improved protein‐bound toxin removal

Acta Physiologica, 2017-02, Vol.219 (2), p.510-520

2017

Volltextzugriff (PDF)

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

American journal of transplantation, 2004-01, Vol.4, p.13-53

2004

Volltextzugriff (PDF)

Chronic renal failure

Deutsche medizinische Wochenschrift (1946), 2011-08, Vol.136 (31-32), p.1591

2011

Volltextzugriff (PDF)

1 – 25 von 651

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(599)
Mit Volltextzugriff
(517)

Publikationsform

Artikel
(651)

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long‐term outcome of enzyme‐replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications

Chronic kidney disease and statin therapy: to treat or not to treat?

A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease

Rare lysosomal disease registries: lessons learned over three decades of real-world evidence

Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study

First Treatment of Relapsing Rapidly Progressive IgA Nephropathy With Eculizumab After Living Kidney Donation: A Case Report

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease

Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials

The D313Y genotype—Pathogenic mutation or polymorphism?

Stratification of Fabry mutations in clinical practice: a closer look at α‐galactosidase A‐3D structure

Low homoarginine concentration is a novel risk factor for heart disease

Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration

Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study

Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry

Ocular sarcoidosis

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

Clinical benefit of enzyme replacement therapy in Fabry disease

Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome

Impact of immunosuppressive therapy on therapy‐neutralizing antibodies in transplanted patients with Fabry disease

C‐reactive protein a marker for all‐cause and cardiovascular mortality in haemodialysis patients

Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry

Haemodiafiltration at increased plasma ionic strength for improved protein‐bound toxin removal

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

Chronic renal failure

Aktive Filter

Suchergebnisse filtern